{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T01:27:48Z","timestamp":1783733268364,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T00:00:00Z","timestamp":1543881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008599","name":"Alzheimerfonden","doi-asserted-by":"publisher","award":["AF-745101"],"award-info":[{"award-number":["AF-745101"]}],"id":[{"id":"10.13039\/501100008599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007435","name":"\u00c5ke Wiberg Stiftelse","doi-asserted-by":"publisher","award":["M17-0251"],"award-info":[{"award-number":["M17-0251"]}],"id":[{"id":"10.13039\/100007435","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009673","name":"Gun och Bertil Stohnes Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009673","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010773","name":"Demensf\u00f6rbundet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010773","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003792","name":"Hj\u00e4rnfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Regional Agreement on Medical Training and Clinical Research (ALF) between the Stockholm County Council and Karolinska Institutet"},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["02695, 05817, 06086"],"award-info":[{"award-number":["02695, 05817, 06086"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001729","name":"Stiftelsen f\u00f6r\u00a0Strategisk Forskning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001729","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010815","name":"Stiftelsen f\u00f6r Gamla Tj\u00e4narinnor","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010815","id-type":"DOI","asserted-by":"publisher"}]},{"name":"EU FP7 large-scale integrating project INMiND"},{"name":"Karolinska Institutet foundations"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00259-018-4217-7","type":"journal-article","created":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T07:27:03Z","timestamp":1543908423000},"page":"348-356","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Longitudinal association between astrocyte function and glucose metabolism in autosomal dominant Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"46","author":[{"given":"Stephen F.","family":"Carter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Chiotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agneta","family":"Nordberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6639-8141","authenticated-orcid":false,"given":"Elena","family":"Rodriguez-Vieitez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,4]]},"reference":[{"issue":"5","key":"4217_CR1","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/j.1471-4159.1977.tb10649.x","volume":"28","author":"L Sokoloff","year":"1977","unstructured":"Sokoloff L, Reivich M, Kennedy C, Des Rosiers MH, Patlak CS, Pettigrew KD, et al. The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem. 1977;28(5):897\u2013916.","journal-title":"J Neurochem"},{"issue":"6","key":"4217_CR2","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","volume":"13","author":"B Dubois","year":"2014","unstructured":"Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, et al. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria. Lancet Neurol. 2014;13(6):614\u201329. https:\/\/doi.org\/10.1016\/S1474-4422(14)70090-0 .","journal-title":"Lancet Neurol"},{"issue":"3","key":"4217_CR3","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nn.4492","volume":"20","author":"ER Zimmer","year":"2017","unstructured":"Zimmer ER, Parent MJ, Souza DG, Leuzy A, Lecrux C, Kim HI, et al. [18F]FDG PET signal is driven by astroglial glutamate transport. Nat Neurosci. 2017;20(3):393\u20135. https:\/\/doi.org\/10.1038\/nn.4492 .","journal-title":"Nat Neurosci"},{"issue":"6","key":"4217_CR4","first-page":"445","volume":"1","author":"PJ Magistretti","year":"1996","unstructured":"Magistretti PJ, Pellerin L. The contribution of astrocytes to the 18F-2-deoxyglucose signal in PET activation studies. Mol Psychiatry. 1996;1(6):445\u201352.","journal-title":"Mol Psychiatry"},{"issue":"22","key":"4217_CR5","doi-asserted-by":"publisher","first-page":"10625","DOI":"10.1073\/pnas.91.22.10625","volume":"91","author":"L Pellerin","year":"1994","unstructured":"Pellerin L, Magistretti PJ. Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci U S A. 1994;91(22):10625\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4-5","key":"4217_CR6","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1159\/000017324","volume":"20","author":"L Pellerin","year":"1998","unstructured":"Pellerin L, Pellegri G, Bittar PG, Charnay Y, Bouras C, Martin JL, et al. Evidence supporting the existence of an activity-dependent astrocyte-neuron lactate shuttle. Dev Neurosci. 1998;20(4-5):291\u20139. https:\/\/doi.org\/10.1159\/000017324 .","journal-title":"Dev Neurosci"},{"issue":"3","key":"4217_CR7","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1113\/JP274944","volume":"596","author":"LF Barros","year":"2018","unstructured":"Barros LF, Weber B. CrossTalk proposal: an important astrocyte-to-neuron lactate shuttle couples neuronal activity to glucose utilisation in the brain. J Physiol. 2018;596(3):347\u201350. https:\/\/doi.org\/10.1113\/JP274944 .","journal-title":"J Physiol"},{"issue":"3","key":"4217_CR8","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1113\/JP274945","volume":"596","author":"LK Bak","year":"2018","unstructured":"Bak LK, Walls AB. CrossTalk opposing view: lack of evidence supporting an astrocyte-to-neuron lactate shuttle coupling neuronal activity to glucose utilisation in the brain. J Physiol. 2018;596(3):351\u20133. https:\/\/doi.org\/10.1113\/JP274945 .","journal-title":"J Physiol"},{"key":"4217_CR9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.neurobiolaging.2018.03.014","volume":"67","author":"AG Vlassenko","year":"2018","unstructured":"Vlassenko AG, Gordon BA, Goyal MS, Su Y, Blazey TM, Durbin TJ, et al. Aerobic glycolysis and tau deposition in preclinical Alzheimer's disease. Neurobiol Aging. 2018;67:95\u20138. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.03.014 .","journal-title":"Neurobiol Aging"},{"issue":"1","key":"4217_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s40336-014-0094-7","volume":"3","author":"AG Vlassenko","year":"2015","unstructured":"Vlassenko AG, Raichle ME. Brain aerobic glycolysis functions and Alzheimer's disease. Clin Transl Imaging. 2015;3(1):27\u201337. https:\/\/doi.org\/10.1007\/s40336-014-0094-7 .","journal-title":"Clin Transl Imaging"},{"issue":"8","key":"4217_CR11","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1073\/pnas.0609833104","volume":"104","author":"WJ Powers","year":"2007","unstructured":"Powers WJ, Videen TO, Markham J, McGee-Minnich L, Antenor-Dorsey JV, Hershey T, et al. Selective defect of in vivo glycolysis in early Huntington's disease striatum. Proc Natl Acad Sci U S A. 2007;104(8):2945\u20139. https:\/\/doi.org\/10.1073\/pnas.0609833104 .","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"4217_CR12","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/glia.440080208","volume":"8","author":"J Ekblom","year":"1993","unstructured":"Ekblom J, Jossan SS, Bergstrom M, Oreland L, Walum E, Aquilonius SM. Monoamine oxidase-B in astrocytes. Glia. 1993;8(2):122\u201332. https:\/\/doi.org\/10.1002\/glia.440080208 .","journal-title":"Glia"},{"issue":"9","key":"4217_CR13","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1093\/brain\/awx172","volume":"140","author":"J Tong","year":"2017","unstructured":"Tong J, Rathitharan G, Meyer JH, Furukawa Y, Ang LC, Boileau I, et al. Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders. Brain. 2017;140(9):2460\u201374. https:\/\/doi.org\/10.1093\/brain\/awx172 .","journal-title":"Brain"},{"issue":"7","key":"4217_CR14","first-page":"1255","volume":"36","author":"JS Fowler","year":"1995","unstructured":"Fowler JS, Wang GJ, Logan J, Xie S, Volkow ND, MacGregor RR, et al. Selective reduction of radiotracer trapping by deuterium substitution: comparison of carbon-11-L-deprenyl and carbon-11-deprenyl-D2 for MAO B mapping. J Nucl Med. 1995;36(7):1255\u201362.","journal-title":"J Nucl Med"},{"key":"4217_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/srep16404","volume":"5","author":"M Sch\u00f6ll","year":"2015","unstructured":"Sch\u00f6ll M, Carter SF, Westman E, Rodriguez-Vieitez E, Almkvist O, Thordardottir S, et al. Early astrocytosis in autosomal dominant Alzheimer's disease measured in vivo by multi-tracer positron emission tomography. Sci Rep. 2015;5:16404. https:\/\/doi.org\/10.1038\/srep16404 .","journal-title":"Sci Rep"},{"issue":"Pt 3","key":"4217_CR16","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1093\/brain\/awv404.","volume":"139","author":"E Rodriguez-Vieitez","year":"2016","unstructured":"Rodriguez-Vieitez E, Saint-Aubert L, Carter SF, Almkvist O, Farid K, Sch\u00f6ll M, et al. Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease. Brain. 2016;139(Pt 3):922\u201336. https:\/\/doi.org\/10.1093\/brain\/awv404.","journal-title":"Brain"},{"issue":"3","key":"4217_CR17","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","volume":"256","author":"RC Petersen","year":"2004","unstructured":"Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256(3):183\u201394. https:\/\/doi.org\/10.1111\/j.1365-2796.2004.01388.x .","journal-title":"J Intern Med"},{"issue":"7","key":"4217_CR18","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 1984;34(7):939\u201344.","journal-title":"Neurology"},{"issue":"1","key":"4217_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2967\/jnumed.110.087031","volume":"53","author":"SF Carter","year":"2012","unstructured":"Carter SF, Sch\u00f6ll M, Almkvist O, Wall A, Engler H, Langstrom B, et al. Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG. J Nucl Med. 2012;53(1):37\u201346. https:\/\/doi.org\/10.2967\/jnumed.110.087031 .","journal-title":"J Nucl Med"},{"issue":"4","key":"4217_CR20","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/hbm.10123","volume":"19","author":"A Hammers","year":"2003","unstructured":"Hammers A, Allom R, Koepp MJ, Free SL, Myers R, Lemieux L, et al. Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe. Hum Brain Mapp. 2003;19(4):224\u201347. https:\/\/doi.org\/10.1002\/hbm.10123 .","journal-title":"Hum Brain Mapp"},{"issue":"1-2","key":"4217_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jns.2007.01.057","volume":"255","author":"A Johansson","year":"2007","unstructured":"Johansson A, Engler H, Blomquist G, Scott B, Wall A, Aquilonius SM, et al. Evidence for astrocytosis in ALS demonstrated by [11C](L)-deprenyl-D2 PET. J Neurol Sci. 2007;255(1-2):17\u201322. https:\/\/doi.org\/10.1016\/j.jns.2007.01.057 .","journal-title":"J Neurol Sci"},{"issue":"4","key":"4217_CR22","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/jcbfm.1985.87","volume":"5","author":"CS Patlak","year":"1985","unstructured":"Patlak CS, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab. 1985;5(4):584\u201390. https:\/\/doi.org\/10.1038\/jcbfm.1985.87 .","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"4217_CR23","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neuint.2010.10.013","volume":"58","author":"B Gulyas","year":"2011","unstructured":"Gulyas B, Pavlova E, Kasa P, Gulya K, Bakota L, Varszegi S, et al. Activated MAO-B in the brain of Alzheimer patients, demonstrated by [11C]-L-deprenyl using whole hemisphere autoradiography. Neurochem Int. 2011;58(1):60\u20138. https:\/\/doi.org\/10.1016\/j.neuint.2010.10.013 .","journal-title":"Neurochem Int"},{"issue":"2","key":"4217_CR24","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.2041-210x.2012.00261.x","volume":"4","author":"S Nakagawa","year":"2013","unstructured":"Nakagawa S, Schielzeth H. A general and simple method for obtaining R2 from generalized linear mixed-effects models. Methods Ecol Evol. 2013;4(2):133\u201342. https:\/\/doi.org\/10.1111\/j.2041-210x.2012.00261.x .","journal-title":"Methods Ecol Evol"},{"key":"4217_CR25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol. 1995;57:289\u2013300.","journal-title":"J R Stat Soc Series B Stat Methodol"},{"issue":"5","key":"4217_CR26","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1006\/nimg.2001.0764","volume":"13","author":"FE Turkheimer","year":"2001","unstructured":"Turkheimer FE, Smith CB, Schmidt K. Estimation of the number of \u201ctrue\u201d null hypotheses in multivariate analysis of neuroimaging data. Neuroimage. 2001;13(5):920\u201330. https:\/\/doi.org\/10.1006\/nimg.2001.0764 .","journal-title":"Neuroimage"},{"issue":"4","key":"4217_CR27","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","volume":"164","author":"B Strooper De","year":"2016","unstructured":"De Strooper B, Karran E. The cellular phase of Alzheimer's disease. Cell. 2016;164(4):603\u201315. https:\/\/doi.org\/10.1016\/j.cell.2015.12.056 .","journal-title":"Cell"},{"issue":"9","key":"4217_CR28","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1523\/JNEUROSCI.5098-09.2010","volume":"30","author":"I Allaman","year":"2010","unstructured":"Allaman I, Gavillet M, Belanger M, Laroche T, Viertl D, Lashuel HA, et al. Amyloid-beta aggregates cause alterations of astrocytic metabolic phenotype: impact on neuronal viability. J Neurosci. 2010;30(9):3326\u201338. https:\/\/doi.org\/10.1523\/JNEUROSCI.5098-09.2010 .","journal-title":"J Neurosci"},{"issue":"4","key":"4217_CR29","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nm838","volume":"9","author":"T Wyss-Coray","year":"2003","unstructured":"Wyss-Coray T, Loike JD, Brionne TC, Lu E, Anankov R, Yan F, et al. Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. Nat Med. 2003;9(4):453\u20137. https:\/\/doi.org\/10.1038\/nm838 .","journal-title":"Nat Med"},{"issue":"6","key":"4217_CR30","first-page":"557","volume":"21","author":"W Song","year":"2000","unstructured":"Song W, Zhou LJ, Zheng SX, Zhu XZ. Amyloid-beta 25-35 peptide induces expression of monoamine oxidase B in cultured rat astrocytes. Acta Pharmacol Sin. 2000;21(6):557\u201363.","journal-title":"Acta Pharmacol Sin"},{"issue":"8","key":"4217_CR31","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/nm.3639","volume":"20","author":"S Jo","year":"2014","unstructured":"Jo S, Yarishkin O, Hwang YJ, Chun YE, Park M, Woo DH, et al. GABA from reactive astrocytes impairs memory in mouse models of Alzheimer's disease. Nat Med. 2014;20(8):886\u201396. https:\/\/doi.org\/10.1038\/nm.3639 .","journal-title":"Nat Med"},{"issue":"12","key":"4217_CR32","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/S1474-4422(14)70167-X","volume":"13","author":"A Chio","year":"2014","unstructured":"Chio A, Pagani M, Agosta F, Calvo A, Cistaro A, Filippi M. Neuroimaging in amyotrophic lateral sclerosis: insights into structural and functional changes. Lancet Neurol. 2014;13(12):1228\u201340. https:\/\/doi.org\/10.1016\/S1474-4422(14)70167-X .","journal-title":"Lancet Neurol"},{"issue":"6","key":"4217_CR33","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/jcbfm.2013.19","volume":"33","author":"J Tong","year":"2013","unstructured":"Tong J, Meyer JH, Furukawa Y, Boileau I, Chang LJ, Wilson AA, et al. Distribution of monoamine oxidase proteins in human brain: implications for brain imaging studies. J Cereb Blood Flow Metab. 2013;33(6):863\u201371. https:\/\/doi.org\/10.1038\/jcbfm.2013.19 .","journal-title":"J Cereb Blood Flow Metab"},{"issue":"12","key":"4217_CR34","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1002\/jnr.24075","volume":"95","author":"C Acosta","year":"2017","unstructured":"Acosta C, Anderson HD, Anderson CM. Astrocyte dysfunction in Alzheimer disease. J Neurosci Res. 2017;95(12):2430\u201347. https:\/\/doi.org\/10.1002\/jnr.24075 .","journal-title":"J Neurosci Res"},{"key":"4217_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13441","volume":"7","author":"JK Hefendehl","year":"2016","unstructured":"Hefendehl JK, LeDue J, Ko RW, Mahler J, Murphy TH, MacVicar BA. Mapping synaptic glutamate transporter dysfunction in vivo to regions surrounding Abeta plaques by iGluSnFR two-photon imaging. Nat Commun. 2016;7:13441. https:\/\/doi.org\/10.1038\/ncomms13441 .","journal-title":"Nat Commun"},{"issue":"5","key":"4217_CR36","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/ana.410400512","volume":"40","author":"E Masliah","year":"1996","unstructured":"Masliah E, Alford M, DeTeresa R, Mallory M, Hansen L. Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease. Ann Neurol. 1996;40(5):759\u201366. https:\/\/doi.org\/10.1002\/ana.410400512 .","journal-title":"Ann Neurol"},{"key":"4217_CR37","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1750-1326-6-55","volume":"6","author":"M Olabarria","year":"2011","unstructured":"Olabarria M, Noristani HN, Verkhratsky A, Rodriguez JJ. Age-dependent decrease in glutamine synthetase expression in the hippocampal astroglia of the triple transgenic Alzheimer's disease mouse model: mechanism for deficient glutamatergic transmission? Mol Neurodegener. 2011;6:55. https:\/\/doi.org\/10.1186\/1750-1326-6-55 .","journal-title":"Mol Neurodegener"},{"issue":"4","key":"4217_CR38","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/ana.10311","volume":"52","author":"JM Pascual","year":"2002","unstructured":"Pascual JM, Van Heertum RL, Wang D, Engelstad K, De Vivo DC. Imaging the metabolic footprint of Glut1 deficiency on the brain. Ann Neurol. 2002;52(4):458\u201364. https:\/\/doi.org\/10.1002\/ana.10311 .","journal-title":"Ann Neurol"},{"issue":"10","key":"4217_CR39","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.2967\/jnumed.118.208009","volume":"59","author":"RJ Tyacke","year":"2018","unstructured":"Tyacke RJ, Myers JFM, Venkataraman A, Mick I, Turton S, Passchier J, et al. Evaluation of (11)C-BU99008, a positron emission tomography ligand for the Imidazoline2 binding site in human brain. J Nucl Med. 2018;59(10):1597\u2013602. https:\/\/doi.org\/10.2967\/jnumed.118.208009 .","journal-title":"J Nucl Med"},{"issue":"348","key":"4217_CR40","doi-asserted-by":"publisher","first-page":"348ra96","DOI":"10.1126\/scitranslmed.aaf6667","volume":"8","author":"SJ Finnema","year":"2016","unstructured":"Finnema SJ, Nabulsi NB, Eid T, Detyniecki K, Lin SF, Chen MK, et al. Imaging synaptic density in the living human brain. Sci Transl Med. 2016;8(348):348ra96. https:\/\/doi.org\/10.1126\/scitranslmed.aaf6667 .","journal-title":"Sci Transl Med"},{"issue":"10","key":"4217_CR41","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1001\/jamaneurol.2018.1836","volume":"75","author":"MK Chen","year":"2018","unstructured":"Chen MK, Mecca AP, Naganawa M, Finnema SJ, Toyonaga T, Lin SF, et al. Assessing synaptic density in Alzheimer disease with synaptic vesicle glycoprotein 2A positron emission tomographic imaging. JAMA Neurol. 2018;75(10):1215\u2013224. https:\/\/doi.org\/10.1001\/jamaneurol.2018.1836 .","journal-title":"JAMA Neurol"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-018-4217-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-018-4217-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-018-4217-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T00:04:17Z","timestamp":1720829057000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-018-4217-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,4]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["4217"],"URL":"https:\/\/doi.org\/10.1007\/s00259-018-4217-7","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,4]]},"assertion":[{"value":"30 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Approval was obtained from the regional Human Ethics Committee of Stockholm and the Faculty of Medicine and Radiation Hazard Ethics Committee of Uppsala University Hospital, Sweden. The study was conducted in accordance with the principles of the Declaration of Helsinki and its subsequent revisions.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All participants provided written informed consent to participate in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}